Zepbound Nausea: How Common, How Long It Lasts, What Helps
Yes. In the Zepbound trials, 29% of people on 10 mg had nausea, against 8% on placebo: about 4 times the placebo rate. It is the most common side effect in that table. Smaller, slower meals help most.
- In the Zepbound label
- Yes, with a rate
- On Zepbound 10 mg
- 29%
- On placebo
- 8%
- Rank in the label table
- 1 of 16
A quick look at Zepbound
Its half-life is 5 to 6 days: after 5.5 d, half is gone, and about 3% remains after five half-lives (27.5 d).
The 72-week SURMOUNT-1 results were 20.9% of body weight, compared with 3.1% for placebo.
The monthly figures are in US dollars. They cover the list price and self-pay offers. Each came from the maker's price page.
Sources: FDA label (DailyMed), Eli Lilly 1 2, cnbc.com.
How often it shows up with Zepbound compared with placebo
In the label trials, nausea with Zepbound is listed for each dose group. The same trial includes placebo as its comparison group.
| Medicine and dose | Nausea | Placebo | More than placebo | People in the trials |
|---|---|---|---|---|
| Zepbound 5 mg | 25% | 8% | +17 points | Adults with obesity or overweight (weight management) |
| Zepbound 10 mg | 29% | 8% | +21 points | Adults with obesity or overweight (weight management) |
| Zepbound 15 mg | 28% | 8% | +20 points | Adults with obesity or overweight (weight management) |
Source: Zepbound label (DailyMed).
Nausea on Zepbound and other GLP-1s compared
Each label covers its own trials, which included different groups of people. Treat this comparison as a rough guide. Treat it as a rough guide.
The table also lists the pill forms: Rybelsus, Foundayo.
| Medicine | Highest rate in the label | Dose group | Placebo | People in the trials |
|---|---|---|---|---|
| 44% | 2.4 mg | 16% | Adults with obesity or overweight (weight management) | |
| Byetta | 44% | all doses | 18% | Adults with type 2 diabetes |
| 39.3% | all doses | 13.8% | Adults with obesity or overweight (weight management) | |
| 35% | 17.2 mg | 10% | Adults with obesity or overweight (weight management) | |
| 29% | 10 mg | 8% | Adults with obesity or overweight (weight management) | |
| 21.1% | 1.5 mg | 5.3% | Adults with type 2 diabetes | |
| 20.3% | 1 mg | 6.1% | Adults with type 2 diabetes | |
| 20% | 14 mg | 6% | Adults with type 2 diabetes | |
| 20% | 1.8 mg | 5% | Adults with type 2 diabetes | |
| 18% | 15 mg | 4% | Adults with type 2 diabetes |
Source labels: Ozempic label (DailyMed), Wegovy label (DailyMed), Rybelsus label (DailyMed), Mounjaro label (DailyMed), Zepbound label (DailyMed), Foundayo label (DailyMed), Trulicity label (DailyMed), Saxenda label (DailyMed), Victoza label (DailyMed), Byetta label (DailyMed).
Source: FDA label (DailyMed).
Why it happens on Zepbound
These medicines slow down how quickly your stomach empties. Nausea can come from food sitting longer, most of all after a big or fatty meal.
Source: health.clevelandclinic.org
What the Zepbound label states
The label says the following about nausea, word for word:
“of the reported events occurred in patients who experienced gastrointestinal adverse reactions leading to dehydration such as nausea, vomiting, or diarrhea [see Adverse Reactions (6.1)].”
Source: FDA label (DailyMed).
What helps, step by step
- Sip ginger or peppermint tea with no sweetener.
- After eating, remain upright rather than lying down.
- Ask your prescriber about having nausea medicine available
- Have smaller meals and stop eating once you feel full. These medicines make the stomach empty more slowly.
- Eat slowly. It takes time for your brain to sense fullness.
- Because fatty, greasy, and sugary foods often cause symptoms, go easy on these foods.
- If it does not ease, tell your prescriber. They might slow how fast the dose goes up, or suggest another GLP-1.
Before taking any drugstore product, check it with the GLP-1 interactions checker.
Source: health.clevelandclinic.org